Publications

5674 Results

RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis

Authors
S Litiere;G Isaac;E DeVries;J Bogaerts;A Chen;J Dancey;R Ford;S Gwyther;O Hoekstra;E Huang;N Lin;Y Liu;S Mandrekar;LH Schwartz;L Shankar;P Therasse;L Seymour;RECIST Working Group
Journal / Conference
Journal of Clinical Oncology May 1;37(13):1102-1110; Mar 12:JCO1801100. doi: 10.1200/JCO.18.01100. [Epub ahead of print]
Year
2019
Research Committee(s)
Melanoma and Multiple sites
PMID
PMID30860949
PMC
PMC6494357
Study Number(s)
S0438

Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes. [Review]

Authors
DB Doroshow;MF Sanmamed;K Hastings;K Politi;DL Rimm;L Chen;I Melero;KA Schalper;RS Herbst
Journal / Conference
Clinical Cancer Research Aug 1;25(15):4592-4602; Mar 1. pii: clincanres.1538.2018. doi: 10.1158/1078-0432.CCR-18-1538. [Epub ahead of print]
Year
2019
Research Committee(s)
Lung
PMID
PMID30824587
PMC
PMC6679805
Study Number(s)
S1400

EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis [Review]

Authors
F Agustoni;K Suda;H Yu;S Ren;CJ Rivard;K Ellison;C Caldwell;L Roseboom;KA Brovsky;F Hirsch
Journal / Conference
Cancer Treatment Reviews Jan;72:15-27
Year
2019
Research Committee(s)
Lung
PMID
PMID30445271
Study Number(s)
S0342, S0536, S0819

Clinical prognostic model for older patients with advanced non-small cell lung cancer

Authors
AK Ganti;X Wang;T Stinchcombe;Y Wang;J Bradley;HJ Cohen;K Kelly;R Paulus;SS Ramalingam;EE Vokes;H Pang
Journal / Conference
Journal of Geriatric Oncology Feb 20. pii: S1879-4068(18)30197-8. doi: 10.1016/j.jgo.2019.02.007. [Epub ahead of print]
Year
2019
Research Committee(s)
Lung
PMID
PMID30797707
Study Number(s)
S0023, S0027, S0536, SWOG-9019, SWOG-9308, SWOG-9429, SWOG-9504, SWOG-9509, S9712

Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer

Authors
R Mehta;W Barlow;K Albain;T Vandenberg;S Dakhil;N Tirumali;DL Lew;D Hayes;J Gralow;H Linden;R Livingston
Journal / Conference
New England Journal of Medicine Mar 28;380(13):1226-1234
Year
2019
Research Committee(s)
Breast
PMID
PMID30917258
PMC
PMC6885383
Study Number(s)
S0226

Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial

Authors
X Li;S Warren;V Pelekanou;V Wali;A Cesano;M Liu;P Danaher;N Elliott;Z Nahleh;D Hayes;G Hortobagyi;W Barlow;C Hatzis;L Pusztai
Journal / Conference
Journal for ImmunoTherapy of Cancer Apr 10;7(1):88
Year
2019
Research Committee(s)
Breast
PMID
PMID30967156
PMC
PMC6457012
Study Number(s)
S0800

Dose-Adjusted EPOCH-R Compared with R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase 3 Intergroup Trial Alliance/CALGB 50303

Authors
N Bartlett;WH Wilson;S Yung;E Hsi;MJ Maurer;L Pederson;M-Y Polley;B Pitcher;B Cheson;B Kahl;J Friedberg;L Staudt;N Wagner Johnston;KA Blum;JS Abramson;N Reddy;J Winter;JE Chang;A Gopal;A Chadburn;S Mathew;RI Fisher;KL Richards;H Schoder;A Zelenetz;JP Leonard
Journal / Conference
Journal of Clinical Oncology Jul 20;37(21):1790-1799
Year
2019
Research Committee(s)
Lymphoma
PMID
PMID30939090
PMC
PMC6774813

Factors associated with osteonecrosis of the jaw in women with breast cancer receiving highdose bisphosphonates to prevent breast cancer metastases as part of the SWOG 0307 trial

Authors
D Kizub;J Miao;M Schubert;A Paterson;M Clemons;E Dees;J Ingle;CI Falkson;W Barlow;G Hortobagyi;J Gralow
Journal / Conference
J Clin Oncol 37, 2019 (suppl; abstr 552); ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), poster session
Year
2019
Research Committee(s)
Breast
Study Number(s)
S0307

Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases: SWOG S0702, NCT00874211

Authors
C Van Poznak;J Unger;A Darke;C Moinpour;R Bagramian;L Hansen;J Floyd;S Dakhil;D Lew;J Wade;M Fisch;NL Henry;D Hershman;J Gralow
Journal / Conference
J Clin Oncol 37 (suppl; abstr 11502);ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), oral
Year
2019
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S0702

S1206: A Dose-Finding Study followed by a Phase II Randomized, Placebo-Controlled Trial of Chemoradiotherapy (CRT) with or without Veliparib in Stage III Non-Small Cell Lung Cancer (NSCLC)

Authors
A Argiris;J Miao;M Cristea;AM Chen;J Sands;RH Decker;S Gettinger;M Daly;BA Faller;KS Albain;R Yanagihara;LL Garland;L Byers;D Wang;M Koczywas;M Redman;K Kelly;D Gandrara
Journal / Conference
J Clin Oncol 37, 2019 (suppl; abstr 552); ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), poster session
Year
2019
Research Committee(s)
Lung
Study Number(s)
S1206 (8811)